- 神经系统疾病的中西医诊疗方案
- 樊永平主编
- 1349字
- 2024-06-12 18:13:39
参考文献
[1]周仲瑛.中医内科学(普通高等教育“十五”国家级规划教材)[M].北京:中国中医药出版社,2003.
[2]石学敏.针灸学(新世纪全国高等中医药院校规划教材)[M].北京:中国中医药出版社,2017.
[3]贾建平.神经病学(第9版)[M].北京:人民卫生出版社,2018.
[4]樊永平,周纡,熊飏,等.258例急性中风中医证型变化的观察及小复方辨证治疗在卒中单元中的疗效评价[J].中华中医药杂志,2006,21(1):23-26.
[5]胡璘媛,樊永平.应用中药活性成分治疗脑出血的机制研究[J].中国中西医结合杂志,2006,26(4):376-380.
[6]中华医学会神经病学分会,中华医学会神经病学分会神经康复学组,中华医学会神经病学分会脑血管病学组.中国脑卒中早期康复治疗指南[J].中华神经科杂志,2017,50(6):405-412.
[7]中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南(2018)[J].中华神经科杂志,2018,51(9):666-682.
[8]王学建,汪志峰,陈杨,等.电针与康复训练治疗脑出血偏瘫52例临床观察[J].转化医学电子杂志,2018,5(12):32-34.
[9]Chinese Society of Neurology,Chinese Stroke Society.中国脑出血诊治指南(2019)[J].中华神经科杂志,2019(12):994-1005.
[10]边俊莉.活血化瘀中药汤剂治疗脑出血急性期的临床效果[J].内蒙古中医药,2019,38(8):31-32.
[11]何流,邱玲,欧阳建彬,等.头针治疗脑出血的研究进展[J].湖南中医杂志,2020,36(12):160-162.
[12]夏婕.中频脉冲治疗仪结合电针康复护理在脑出血偏瘫患者中的应用效果[J].医疗装备,2020,33(17):196-197.
[13]吴明玉,陆东海.血管CTA成像技术在脑出血早期诊断及其病因判断中的临床意义研究[J].影像研究与医学应用,2021,5(18):100-101.
[14]Broderick J P,Brott T G,Duldner JE,et al.Volume of intracerebral hemorrhage.A powerful and easy-to-use predictor of 30-day mortality[J].Stroke,1993,24(7):987-993.
[15]Liu M,Wu B,Wang WZ,et al.Stroke in China:epidemiology,prevention,and management strategies[J].Lancet Neurol,2007,6(5):456-464.
[16]Kimura K,Iguchi Y,Inoue T,et al.Hyperglycemia independently increases the risk of early death in acute spontaneous intracerebral hemorrhage[J].J Neurol Sci,2007,255(1-2):90-94.
[17]Van Asch C J,Luitse M J,Rinkel GJ,et al.Incidence,case fatality,and functional outcome of intracerebral hemorrhage over time,according to age,sex,and ethnic origin:a systematic review and meta-analysis[J].Lancet Neurol,2010,9(2):167-176.
[18]Yang J,Liu M,Zhou J,et al.Edaravone for acute intracerebral haemorrhage[J].Cochrane Database Syst Rev,2011,16(2):CD007755.
[19]Tsai CF,Thomas B,Sudlow CL.Epidemiology of stroke and its subtypes in Chinese vs white populations:a systematic review[J].Neurology,2013,81(3):264-272.
[20]Rodriguez-Luna D,Piñeiro S,Rubiera M,et al.Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage[J].Eur J Neurol,2013,20(9):1277-1283.
[21]Butcher K S,Jeerakathil T,Hill M,et al.The intracerebral hemorrhage acutely decreasing arterial pressure trial[J].Stroke,2013,44(3):620-626.
[22]Tian Y,Wang Z,Jia Y,et al.Intracranial pressure variability predicts short-term outcome after intracerebral hemorrhage:a retrospective study[J].J Neurol Sci,2013,330(1-2):38-44.
[23]Feigin V L,Forouzanfar M H,Krishnamurthi R,et al.Global Burden of Diseases,Injuries,and Risk Factors Study 2010(GBD 2010)and the GBD Stroke Experts Group.Global and regional burden of stroke during 1990-2010:findings from the Global Burden of Disease Study 2010[J].Lancet,2014,18(1):245-54.
[24]Yang J,Cui X,Li J,et al.Edaravone for acute stroke:meta-analyses of data from randomized controlled trials[J].Dev Neurorehabil,2015,18(5):330-335.
[25]Morgenstern L B,Hemphill J C 3rd,Anderson C,et al.Guidelines for the management of spontaneous intracerebral hemorrhage:aguideline for healthcare professionals from the American Heart Association/American Stroke Association[J].Stroke,2015,46(7):2032-2060.
[26]Chinese Society of Neurology,Chinese Society of Neurorehabilitation,Chinese Stroke Society.Guidelines for early rehabilitation of stroke in China[J].Chin J Neurol,2017,50(6):405-412.
[27]Chinese Society of Neurology,Chinese Stroke Society.Chinese guidelines for diagnosis and treatment of acute ischemicstroke 2018[J].Chin J Neurol,2018,51(9):666-682.
[28]Wu S,Wu B,Liu M,et al.China Stroke Study Collaboration.Stroke in China:advances and challenges in epidemiology,prevention,and management[J].Lancet Neurol,2019,18(4):394-405.